Oral Concurrent Session IV – Friday, February 4^th, 2022 (12:15-2:45pm CST)

Oral Concurrent Session VI – Friday, February 4^th, 2022 (12:15-2:45pm CST)

Tita AT, Cheng C, Grantz KL, Grobman W, Siscione A, Skupski D, Palomares K, Vena J, Newman R for the ECHO National Fetal Growth Study Consortium.

Poster Session I – Thursday, February 3, 2022 (9:30-11:00am CST)

McIlwraith CA, Howard H, Brocato B, Sanusi AA, Xue Y, Szychowski J, Perez W, Battarbee AN. IMPORTANT OF GLYCEMIC CONTROL ACROSS ADVANCING GESTATION IN PREVENTING ADVERSE MATERNAL AND NEONATAL OUCOMES IN PATIENTS WITH PREGESTATIONAL DIABETES

Cozzi GD, Yuanfan Y, Mbah R, Mbunwe DM, Pekwarake S, Bunwi EY, Fondzeyuf A, Ngong MG, Dionne Odom J, Harper LM, Jauk VC, Carlo WA, Halle-Ekane G,, Tih P, Szychowski JM, Tita AT, Subramaniam A. PREDICTING PERIPARTUM INFECTION IN LABORING PATIENTS AT HIGH RISK IN CAMEROON, AFRICA

Knupp R, Yuanfan Y, Kincaid K, Szychowski J, Owen J, Subramaniam A. PRENATAL GENETIC SCREENING AND THE LATINX OBSTETRIC PATIENT

Knupp R, Nassel A, Blanchard CT, Szychowski JM, Battarbee AN, Subramaniam A. THE ASSOCIATION BETWEEN THE DEGREE OF SOCIAL VULNERABILITY OF HOME RESIDENCE AND ADVERSE PERINATAL OUTCOMES

Sanusi AA, Battarbee AN, McGwin G, Subramaniam A. ASPIRIN FOR PREECLAMPSIA PROPHYLAXIS IN PATIENTS WITH STAGE 1 HYPERTENSION IN PREGNANCY

Oben A, Boateng E, Blanchard C, Szychowski JM, Battarbee AN. RACIAL DISPARITIES IN MATERNAL AND NEONATAL OUTCOMES OF PREGNANT PATIENTS WITH DIABETES

Seasely AR, Patton S, Owen J,, Austin E, Hurst ACE, Subramaniam A. DOES PRENATAL GENETIC TESTING IMPACT RESOURCE UTILIZATION IN PREGNANCIES WITH SUSPECTED SKELETAL DYSPLASIA?

Patton S, Seasely AR, Owen J, Austin E, Hurst ACE, Subramaniam A. CHANGES IN PRENATAL GENETIC TESTING INI CASES OF SUSPECTED SKELETAL DYSPLASIA OVER A 10-YEAR PERIOD

Dunk S, Yuanfan Y, Cozzi GD, Mbah R, Mbunwe DM, Pekwarake S, Bunwi EY, Fondzeyuf A, Ngong MG, Dionne-Odom J, Harper LM, Jauk VC, Carlo WA, Halle-Ekane G,, Tih P, Szychowski JM, Tita AT, Subramaniam A. PREDICTING POSTPARTUM HEMORRHAGE IN LABORING PATIENTS IN CAMEROON, AFRICA

Tita A for the Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Trial Consortium. DOES AJUNCTIVE AZITHROMYCIN ANTIBIOTIC PROPHYLAXIS REDUCE RACIAL-ETHNIC DISPARITIES IN MATERNAL INFECTION?

Kincaid J, Yuanfan Y, Knupp RJ, Szychowski J, Owen J,, Subramaniam A. DOES THE PREDICTIVE VALUE OF MATERNAL SERUM ALPHA-FETOPROTEIN ON ADVERSE PREGNANCY OUTCOMES VARY BY RACE/ETHNICITY

Poster Session II – Thursday, February 3^rd (2:45-4:15pm CST)

Subramaniam A, Owen J, Parks M, Chandler-Laney P, Szychowski J, Tita A.  PERINATAL MORBIDITY PREDICTION UTILIZING ULTRASONOGRAPHIC CENTRAL ADIPOSITY MEASURES COMPARED TO BMI IN PATIENTS WITH BMI ≥40

Davis A, Blanchard CT, Subramaniam A, Sinkey R, Tita AT, Battarbee AN. TAILORED PHYSIOLOGIC TREATMENT OF SEVERE HYPERTENSION IN PREGNANCY: A NOVEL APPROACH TO HYPERTENSION MANAGEMENT

Sanusi A, Xue Y, Brocato BE, Howard H, McIlwraith CA, Perez W, Szychowski JM, Battarbee AN. ASSOCIATION OF CONTINUOUS GLUCOSE MONITORING METRICS AND GLYCATED HEMOGLOBIN (HbA1C) WITH PERINATAL OUTCOMES

Brocato B, Howard H, McIlwraith C, Sanusi A, Xue Y, Szychowski J, Casey B, Battarbee AN. GLYCEMIC CONTROL ACCORDING TO CONTINUOUS GLUCOSE MONITORING (CGM): DOES TIME OF DAY MATTER?

Poster Session III – Friday, February 4^th (9:30-11:00am CST)

McIlwraith CA, Sanusi AA, McGwin G, Battarbee AN, Subramaniam A. SEVERE MATERNAL MORBIDITY (SMM) IN SUBSEQUENT PREGNANCIES AMONG PATIENTS WITH AN WITHOUT PREVIOUS SMM 

Brocato B, Szychowski J, Owen J.  LATENCY DURATION BEYOND VIABILITY IN WOMEN UNDERGOING ULTRASOUND-INDCIATED CERCLAGE 

Sanusi AA, Xue Y, McIlwraith CA, Howard H, Szychowski JM, Brocato BE, Casey BM, Battarbee AN. ASSOCIATION BETWEEN CONTINUOUS GLUCOSE MONITORING METRICS AND PERINATAL OUTCOMES IN PREGNANCIES COMPLICATED BY PREGESTATIONAL DIABETES

Sanusi AA, Xue Y, Gray M, Curtis P, Mohr S, Szychowski JM, Harper LM, Sinkey R.   DELIVERY TIMING FOR THE OPIOID-EXPOSED INFANT

Page MR, Lu MY, Blanchard CT, Ausbeck EB, Oglesby KR, Lazenby AJ, Cozzi GD, Rogers RD, Bushman ET, Kaplan ER, Ruzic MF, Mahalingham M, Dunk S, Champion M, Kamal MZ, Howard H, Kim DJ, Szychowski JM, Subramaniam A, Casey B. POSTPARTUM WOUND MORBIDITY ACCORDING TO TIMING OF PROPHYLACTIC ANTICOAGULATION ADMINISTRATION

Champion ML, Blanchard CT, Cozzi G, Casey BM, Tita AT, Szychowski J, Lu MY, Subramaniam A. GESTATIONAL AGE AT ASPIRIN INITIATION AND PERNATAL OUTCOMES

Champion ML, Jauk VC, Szychowski JM, Battarbee AN, Tita T, Casey BM, Subramaniam A. DURATION OF INTRAPARTUM AMPICILLIN PROPHYLAXIS AND NEONATAL OUTCOMES.

Patton S, Seasely AR, Owen J, Austin E, Hurst ACE, Subramaniam A. EVALUATING SHORT TERM NEONATAL OUTCOMES OF INFANTS WITH SUSPECTED SKELETAL DYSPLASIA BY MODE OF DELIVERY

Cozzi GD, Blanchard CT, Knupp RJ, Szychowski JM, Subramaniam A, Battarbee AN.  OPTIMAL PRE-DELIVERY HEMOGLOBIN TO REDUCE TRANSFUSION AND ADVERSE PERINATAL OUTCOMES

Tita AT, Cheng C, Grantz KL, Grobman W, Siscione A, Skupski D, Palomares K, Vena J,, Newman R for the ECHO National Fetal Growth Study Consortium. CHILDHOOD NEURODEVELOPMENTAL OUTCOMES AND HYPERTENSIVE DISORDERS OF PREGNANCY

Seasely AR, Jauk VC, Szychowski JM, Namasivayam A, Tita AT, Casey B. NEONATAL COMPLICATION RATES IN PERIVIABLE INFANTS ACCORDING TO GESTATIONAL AGE AT DELIVERY

Seasely AR, Jauk VC, Szychowski JM, Namasivayam A, Tita AT, Casey B. MATERNAL COMPLICATIONS AND LONGITUDINAL SURVIVAL IN PERIVIABLE ADMISSIONS ACCORDING TO GESTATIONAL AGE AT DELIVERY 

Subramaniam A, Owen J, Parks M, Chandler-Laney P, Szychowski J,, Tita A.  PREDICTING CESAREAN IN PATIENTS WITH NORMAL BMI VS BMI ≥40 USING CENTRAL ADIPOSITY MEASURES     

Poster Session IV – Friday, February 4^th (2:45-4:15pm)

Gardner AB, Champion M, Battarbee AN. EXPLORING RACIAL/ETHNIC GROUPS AT RISK FOR GESTATIONAL DIABETES MELLITUS: GENETIC DIFFERENCES OR EFFECTS OF RACISM?

Champion ML, Martin KD, Lawson SM, Subramaniam A, Battarbee AN. THE IMPACT OF DIABETES AND OBESITY ON POSTOPERATIVE COMPLICATIONS AFTER CESAREAN DELIVERY 

Cozzi GD, Jauk VC, Szychowski JM, Tita A, Battarbee AN, Subramaniam A.  PARTICIPATION IN OBSTETRIC STUDIES IS ASSOCIATED WITH IMPROVED PREGNANCY OUTCOMES 

Oben A, Ruzic F, Blanchard C, Battarbee A, Casey B, Tita A, Subramaniam A. POST-CESAREAN INFECTIONS BEFORE AND AFTER IMPLEMENTATION OF ADJUNCTIVE AZITHROMYCIN: DOES PRESENT OF CHORIOAMNIONITIS MATTER?

Seasely AR, Jauk VC, Szychowski JM, Namasivayam A, Tita, AT, Casey B.  PERIVIABLE MULTIPLE GESTATIONS: ARE NEONATAL COMPLICATIONS AND SURVIVAL DIFFERENT THAN SINGLETONS BORN AT THE SAME GESTATIONAL AGE?

Seasely AR, Jauk VC, Szychowski JM, Manasivayam A, Tita AT, Casey B.  NEONATAL COMPLICATION, SURVIVAL AND INTERVENTION RATES IN 22 WEEK PERIVIABLE NEWBORNS ACCORDING TO CORTICOSTEROID ADMINISTRATION

Fleenor R, Blanchard CT, Seasely AR, Szychowski JM, Casey B, Subramaniam A.  INFECTION MORBIDITY AFTER DISCHARGE IN WOMEN WITH “BENIGN? POSTPARTUM FEVER DURING DELIVERY HOSPITALIZATION

Seasely AR, Gaonkar M, Battarbee AN, Casey BM, Sinkey R, Dionne-Odom J, Szychowski JM, Tita AT, Subramaniam A. ARE ABNORMAL COAGULATION STUDIES UPON HOSPITAL ADMISSION IN GRAVIDAS WITH COVID-19 ASSOCIATED WITH ADVERSE OUTCOMES?

Toluhi AA, Richardson MR, Zi J, Sinkey R, Knight CC, Budhwani H, Preskitt JK, Szychowski, Wingate MS, Tita AT, Baskin ML, Turan JM. STAKEHOLDER PERSPECTIVES ON RACIAL DISPARITIES IN MATERNAL MORTALITY AND MORBIDITY IN ALABAMA

Shrestha KS, McGwin G, Sanusi A, Battarbee AN, Subramaniam A. MATERNAL RISK FACTORS FOR POSTPARTUM HOSPITAL READMISSIONS